The EMA is investigating the Janssen vaccine.

Coronavirus – second year

It has been more than a year since the Chinese authorities informed the World Health Organization of the emergence of a new rapidly spreading virus. Since then, there hasn’t been anyone in the world who hasn’t heard of the term Covid-19, and more and more people are mourning a relative or friend who ended up with the new disease while existence collapsed in weeks and our entire lives were rewritten from the pandemic. So far, vaccines have been completed, and this in turn raises not only hope, but also many questions, while not only stopping the virus, but also threatening another mutation. You can find the details of this battle in our series of articles.

The European Medicines Agency (EMA) said that a link between the Johnson & Johnson coronavirus vaccine and very rare cases of blood clots has not yet been observed. It has also been indicated that they will continue to test the vaccine.

The Amsterdam-based European Union Pharmacovigilance Authority began investigating a vaccine against a new type of coronavirus developed by pharmaceutical company Janssen Pharmaceutica-Cilag NV, part of the Johnson & Johnson group, on Friday. The role of the vaccine in the formation of blood clots has been studied very rarely after vaccination. So far, four cases have been reported from the United States.

Of the four cases of unusual blood clotting, one occurred during the clinical trial phase and three after the vaccine was administered. One case was fatal. According to the European Union Agency

It is not yet clear if there is a causal relationship between the Janssen vaccine and the low number of blood clots, so he is continuing the investigation that began, and will present its results soon.

On Tuesday, the US health authorities stopped the use of a single dose Johnson & Johnson vaccine against the Coronavirus I suggested, After rare blood clotting disorders occurred in six people a few days after vaccination.

READ  Denmark also tightens: schools and restaurants close

The first shipments of Johnson & Johnson vaccines arrived in the European Union on Monday, but the company followed the US proposal He saidTo delay delivery of vaccines to Europe.

An unnamed European Union spokesman told Reuters that the European Commission had asked the American pharmaceutical company for an explanation for its “totally unexpected” announcement of delaying delivery of a coronavirus vaccine to the European Union. According to the spokesman, the news hit the Brussels Board of Directors unexpectedly, as the company had previously confirmed that it would deliver 55 million doses of the vaccine to the European Union by the end of June. He said the European Commission had contacted the pharmaceutical company to clarify its decision on the delay in delivery.

According to press reports, after the US decision, Belgium and the Netherlands have also decided not to start using the Johnson & Johnson vaccine at this time. Dutch Health Minister Hugo de Jong said at a press conference in The Hague that his country is studying whether to start introducing the vaccine this week. He said he expected the European Medicines Agency to provide information on the outcome of its investigation on Wednesday. The EMA confirmed in a statement Tuesday that the benefits of the Jansen vaccine outweigh the risks of potential side effects.

The vaccine has also been suspended by the Republic of South Africa. Zwaili Mkhize, the country’s health minister, said that we will voluntarily suspend more vaccinations until due diligence checks are done to see if there is a causal relationship between blood clots and the Johnson and Johnson vaccine.

READ  At home: Árpád Habony blows foam again in Tuscany

In this case, also sent questions to the staff, and we were curious as to whether they were planning to delay use of the 28,000 Janssen vaccines that arrived in Hungary on Tuesday, and whether anything would change in the vaccination program on the planned Tolna bus. The working staff responded that the Hungarian authorities were awaiting a decision from the European Medicines Agency on the vaccine. According to the surgical staff, 28,800 doses of the vaccine arrived in Hungary on Tuesday, and they will be the first to be vaccinated in the vaccination buses that are being sent to small settlements starting next week.

If you want to know similar things at other times, like that The Facebook page of HVG Tech’s division, which also provides science news.

The number of independent editorial boards is steadily decreasing, and those that still exist are trying to stay afloat in the light of increasing headwinds. At HVG, we persevere and not give in to pressure, bringing local and international news every day.

That is why we ask you, our readers, to stand by us, support us, join and renew our membership!

We promise to continue doing our best for you in all circumstances!

The Johnson & Johnson vaccine will arrive in Europe in three weeks


By the end of June, 55 million doses of the vaccine could reach the European Union.

The Johnson & Johnson vaccine has been shipped to the European Union

MTI / hvg.huTechnique

28,000 doses of the single dose vaccine will reach Hungary. Sputnik will also launch 140,000 vaccines on Tuesday.